New Shire CEO welcomes broader range of rare disease partners
This article was originally published in Scrip
Executive Summary
Dr Flemming Ornskov, who officially takes the reins as CEO of Shire next week, is starting his new tenure by putting out the welcome mat for innovative small companies and startups looking to partner on treatments for rare diseases.